Clinical trial
EFFECTIVENESS OF ETRASIMOD ON DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES IN ULCERATIVE COLITIS - EFFECT-UC
NCT06294925 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EFFECTIVENESS OF ETRASIMOD ON DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES IN ULCERATIVE COLITIS - EFFECT-UC
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- May 8, 2024
- Completion date
- May 13, 2027
- Enrollment
- 360 (estimated)
- Sites
- 41
Conditions
As the registry lists them; a condition with its own page is linked.